全文获取类型
收费全文 | 47325篇 |
免费 | 2979篇 |
国内免费 | 1113篇 |
专业分类
耳鼻咽喉 | 1533篇 |
儿科学 | 1498篇 |
妇产科学 | 2354篇 |
基础医学 | 1896篇 |
口腔科学 | 1028篇 |
临床医学 | 3902篇 |
内科学 | 4979篇 |
皮肤病学 | 455篇 |
神经病学 | 3345篇 |
特种医学 | 733篇 |
外国民族医学 | 4篇 |
外科学 | 15171篇 |
综合类 | 5284篇 |
一般理论 | 1篇 |
预防医学 | 2776篇 |
眼科学 | 586篇 |
药学 | 2832篇 |
28篇 | |
中国医学 | 365篇 |
肿瘤学 | 2647篇 |
出版年
2024年 | 68篇 |
2023年 | 900篇 |
2022年 | 1409篇 |
2021年 | 2176篇 |
2020年 | 2008篇 |
2019年 | 2144篇 |
2018年 | 2008篇 |
2017年 | 1792篇 |
2016年 | 1832篇 |
2015年 | 1819篇 |
2014年 | 3517篇 |
2013年 | 3527篇 |
2012年 | 2888篇 |
2011年 | 3051篇 |
2010年 | 2697篇 |
2009年 | 2571篇 |
2008年 | 2408篇 |
2007年 | 2335篇 |
2006年 | 2087篇 |
2005年 | 1795篇 |
2004年 | 1484篇 |
2003年 | 1198篇 |
2002年 | 1022篇 |
2001年 | 861篇 |
2000年 | 627篇 |
1999年 | 491篇 |
1998年 | 402篇 |
1997年 | 305篇 |
1996年 | 315篇 |
1995年 | 211篇 |
1994年 | 173篇 |
1993年 | 148篇 |
1992年 | 114篇 |
1991年 | 122篇 |
1990年 | 80篇 |
1989年 | 82篇 |
1988年 | 55篇 |
1987年 | 44篇 |
1986年 | 64篇 |
1985年 | 80篇 |
1984年 | 87篇 |
1983年 | 55篇 |
1982年 | 53篇 |
1981年 | 36篇 |
1980年 | 40篇 |
1979年 | 51篇 |
1978年 | 49篇 |
1976年 | 32篇 |
1975年 | 33篇 |
1974年 | 25篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
目的探讨胎盘植入性疾病的危险因素及妊娠结局。 方法回顾性分析2009年1月至2017年12月广州医科大学附属第三医院/广州重症孕产妇救治中心围产资料数据库中信息完整的单胎妊娠孕妇48 650例临床资料,将这些孕妇分为胎盘植入性疾病组和非胎盘植入性疾病组,分析胎盘植入性疾病的危险因素及其妊娠结局。 结果单因素分析显示,年龄≥35岁、高中教育水平及以下、孕次≥3次、经产妇、人工流产史、剖宫产史、体外受精-胚胎移植受孕、合并前置胎盘是胎盘植入性疾病的相关危险因素(P<0.05)。多因素logistic回归分析显示,胎盘植入性疾病的独立危险因素为剖宫产史(OR=2.254,95%CI:1.917~2.650)、体外受精-胚胎移植受孕(OR=1.591,95%CI:1.212~2.089)、合并前置胎盘(OR=28.282,95%CI:24.338~32.866);与非胎盘植入性疾病产妇相比,患有胎盘植入性疾病产妇早产、剖宫产、产后出血、弥散性血管内凝血、产褥期感染、子宫切除、低出生体重儿、新生儿Apgar评分相对较低(1 min)、产妇入住重症监护病房的发生率明显升高(P<0.05)。 结论剖宫产史、辅助生殖受孕、合并前置胎盘是引起胎盘植入性疾病的独立危险因素,胎盘植入性疾病的妊娠结局不良。 相似文献
62.
目的 评价逐瘀止血汤加减对慢性子宫内膜炎(CE)气虚血瘀证患者妊娠结局的影响及对免疫炎症因子的调节作用。方法 将144例患者随机按数字表法分为观察组和对照组各72例。观察组脱落、失访4例,剔除2例,完成66例;对照组脱落、失访3例,剔除5例,完成65例。两组均给予抗感染治疗14 d。对照组口服妇科千金片,6片/次,3次/d。观察组内服逐瘀止血汤加减,1剂/d。两组疗程均为3个月,并随访6个月。记录治疗前后月经经量、经期和周期变化情况;进行治疗前后宫腔镜和阴道彩色多普勒超声检查,评价子宫内膜形态、子宫内膜容受性(CP)[子宫内膜厚度、阻力指数(RI),搏动指数(PI)和血流指数(FI)]等,并进行子宫内膜病理检查;进行治疗前后气虚血瘀证评分;检测治疗前后月经血白细胞介素-1β(IL-1β),IL-6和肿瘤坏死因子-α(TNF-α)水平和外周血测T淋巴亚群(CD3+,CD4+,CD8+)水平;随访记录妊娠情况和流产情况。进行安全性评价。结果 治疗后观察组经量、经期、周期和月经完全正常率均高于对照组(P<0.05);观察组子宫内膜厚度和FI均高于对照组(P<0.01),RI和PI均低于对照组(P<0.01);观察组月经血IL-1β,IL-6和TNF-α水平均低于对照组(P<0.01);观察组CD3+,CD4+水平和CD4+/ CD8+均高于对照组(P<0.01),CD8+水平低于对照组(P<0.01);在6个月随访期间,观察组妊娠率46.97%(31/66),高于对照组的27.69%(18/65)(χ2=5.197,P<0.05);观察组子宫内膜形态疗效总有效率为96.97%(64/66),高于对照组的86.15%(56/65)(χ2=4.981,P<0.05);观察组子宫内膜病理组织疗效总有效率为95.45%(63/66),高于对照组的84.62%(55/65)(χ2=4.304,P<0.05);观察组综合临床疗效总有效率为93.94%(62/66),高于对照组的81.54%(55/65)(χ2=4.696,P<0.05);两组治疗期间均未发现与中药相关不良反应。结论 逐瘀止血汤加减治疗CE气虚血瘀证患者,可调经月经、减轻临床症状,改善宫腔镜下内膜形态,调节全身和局部的免疫炎症反应,提高了CP,从而改善了妊娠结局,有着较好的综合疗效,且安全。 相似文献
63.
64.
Yu Fan Xiaoling Liao Yuesong Pan Kehui Dong Yilong Wang Yongjun Wang 《Journal of stroke and cerebrovascular diseases》2019,28(1):220-226
Background
The intravenous thrombolysis (IVT) with recombinant tissue plasminogen activator (rt-PA) therapy is safe and efficient during the treatment of acute ischemic stroke. Nonetheless, the different outcomes among various stroke subgroups have limited data with regard to the safety and efficacy of cryptogenic stroke (CS). The present study compared the safety and efficacy when IVT with rt-PA was used for the treatment of CS and the other stroke subtypes.Methods
This study classified the IVT with rt-PA patients within 4.5 hours after stroke onset, based on the trial of ORG 10172 in acute stroke treatment criteria in terms of diagnostic evaluation. The data were obtained from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China database, a large multicenter prospective registry. A multivariable logistic regression model was employed to compare the differences between the subtypes in symptomatic intracerebral hemorrhage (sICH) within 7 days and studied the mortality and the outcome during 90 days.Results
In total, 1118 patients were recruited; of these, 131 (11.7%) suffered from CS and 987 (88.3%) with the other etiology. In the CS group, patients were younger than those in the other etiology groups (P < .001). Moreover, it had a lower prevalence of previous stroke (P?=?.0117), receiving antiplatelet drug in 24 hours prior to thrombolysis (P?=?.0017), and functional independence (mRS > 1 before stroke, P?=?.003). The CS group had lower blood pressure (systolic blood pressure P?=?.0001; diastolic blood pressure; P?=?.0212) before thrombolysis, atrial fibrillation (P < .001), and diabetes mellitus (P?=?.0005). Transient ischemic attack, hypertension, hyperlipidemia, blood glucose, receiving anticoagulants in 24 hours prior to thrombolysis, and standard dosage of rt-PA were equally distributed in both groups. After the adjustment of confounders between the CS and the other subgroups, no obvious differences were observed in sICH rate and mortality (P > .05) The CS patients exhibited excellent recovery (mRS, 0-1; 63.78%) and functional independence (mRS, 0-2; 74.8%) than the large artery atherosclerosis patients.Conclusions
IVT with rt-PA is a safe and effective method for the treatment of CS patients. 相似文献65.
66.
67.
68.
目的 探讨腰硬联合(CSEA)及患者自控镇痛(PCEA)对产程及分娩结局的影响。方法 随机选取2014年1~12月足月待产、无妊娠合并症和并发症初产妇996例,其中503例产妇于活跃期实施CSEA+PCEA镇痛(分娩镇痛组),493例未行分娩镇痛(对照组),分别记录并比较两组产妇各产程时间、子宫收缩、镇痛效果、运动神经阻滞程度、产程中缩宫素的使用率、产后出血率、羊水Ⅲ度污染率、新生儿Apgar评分、产钳助产和剖宫产率。结果 分娩镇痛组第一产程、第二产程较对照组有所延长,差异有统计学意义(P<0.05);第三产程无明显改变;子宫收缩力减弱;分娩镇痛组较对照组镇痛效果显著,差异有统计学意义(P<0.05);运动阻滞程度低;缩宫素使用率、产后出血率、羊水Ⅲ度污染率、及新生儿Apgar评分及产钳助产和剖宫产率两组比较,差异均无统计学意义(P>0.05)。结论 腰硬联合分娩镇痛可能会使第一产程、第二产程延长,对子宫收缩力有一定的影响,但并未增加缩宫素的使用率及产钳助产和剖宫产率,其镇痛效果显著,运动阻滞程度低,对分娩结局无不良影响。 相似文献
69.
《Journal of Clinical Orthopaedics and Trauma》2020,11(3):357-368
BackgroundCharcot neuroarthropathy is a complex condition characterised by progressive deformity, limited treatment options and a high amputation rate. Surgical reconstruction of Charcot foot has been proposed as a method to preserve the foot. However, limited information exists on the different methods of reconstruction available, their outcomes and complications.MethodsWe systematically analysed published data from Jan 1993 to Dec 2018 to assess methods of fixation and associated outcomes for the surgical reconstruction in Charcot neuroarthropathy. Statistical analyses were undertaken to determine the amputation rates, return to ambulation and complications associated with these techniques.ResultsA total of 1116 feet (1089 patients) were reported to have undergone reconstruction with significant heterogeneity in patient selection. Of these, 726 (65%) were reported to undergo internal fixation, 346 feet (31%) external fixation and 44 (4%) undergoing simultaneous internal and external fixation. No single technique demonstrated a significant benefit over the other. Overall, the bone fusion rate was 86.1%. Complications directly attributable to the technique employed were noted in 36% of individuals. The reported post-reconstruction amputation rate was only 5.5% with 91% apparently returning to ambulation.ConclusionsAlthough no preferential method of fixation was identified, we find that the current options for surgical reconstruction could offer limb salvage with a low amputation risk in a highly selected population. However, the lack of controlled studies, inconsistent reporting of outcomes and heterogeneity of patient selection mean that the quality of evidence is low. 相似文献
70.